2型糖尿病患者尿8-oxoGuo(RNA氧化标志物)与心血管及全因死亡风险的关联:前瞻性队列研究
在1863例60岁及以上2型糖尿病患者中,5年随访期间173例死亡(9.3%),其中73例为心血管死亡(42.2%)。校正后RNA氧化倍增与全因死亡HR 2.10(95%CI 1.63-2.71;P<0.001)和心血管死亡HR 1.82(95%CI 1.20-2.77;P=0.005)相关。RNA氧化最高四分位组5年全因死亡绝对风险13.9% vs 最低四分位组6.10%,心血管死亡绝对风险5.49% vs 3.16%。
要点
- 2型糖尿病患者尿8-oxoGuo(RNA氧化标志物)倍增与全因死亡风险升高相关,HR 2.10。
- RNA氧化倍增与心血管死亡风险升高相关,HR 1.82。
- RNA氧化最高四分位组全因和心血管死亡5年绝对风险约为最低四分位组的两倍。
核心结论
- 高RNA氧化与2型糖尿病患者的全因死亡和心血管死亡风险相关。
- 通过长期随访的氧化应激干预可能揭示生物标志物8-oxoGuo的预测潜力。
研究设计与样本
- 前瞻性队列研究,纳入年龄≥60岁的2型糖尿病患者1863例,测量尿核酸氧化生物标志物,并结合生化检测、问卷和中央人口登记信息,采用Cox回归估计对数2转换的RNA氧化的风险比。
主要发现
- 5年随访期间,1863例患者中173例死亡(9.3%),其中73例死于心血管疾病(42.2%)。
- 多因素校正后,RNA氧化倍增与全因死亡风险的HR为2.10(95%CI 1.63-2.71;P<0.001)。
- 多因素校正后,RNA氧化倍增与心血管死亡的HR为1.82(95%CI 1.20-2.77;P=0.005)。
- RNA氧化最高四分位组与最低四分位组的5年全因死亡绝对风险分别为13.9(95%CI 10.8-17.0)与6.10(95%CI 4.00-8.30)。
- RNA氧化最高四分位组与最低四分位组的5年心血管死亡绝对风险分别为5.49(95%CI 3.44-7.55)与3.16(95%CI 1.59-4.73)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cardiovascular mortality risk remains high among patients with type 2 diabetes. Oxidative stress indicated by high urinary excretion of the biomarker for RNA oxidation, 8-oxo-7,8-dihydroguanosine (8-oxoGuo), is associated with an increased risk of death in newly diagnosed and treated patients. We assessed whether 8-oxoGuo is associated with specific cardiovascular and all-cause mortality risk. RESEARCH DESIGN AND METHODS: Urinary biomarkers for nucleic acid oxidation were measured in a cohort of patients with type 2 diabetes aged ≥60 years (n = 1,863), along with biochemical measurements, questionnaire findings, and Central Person Registry information to estimate the hazard ratios (HRs) for log2-transformed RNA oxidation using Cox regression. RESULTS: During the 5-year follow-up, 173 of 1,863 patients had died (9.3%), including 73 patients who died of cardiovascular disease (42.2%). Doubling of RNA oxidation was associated with an HR of all-cause mortality of 2.10 (95% CI 1.63-2.71; P < 0.001) and an HR of cardiovascular death of 1.82 (95% CI 1.20-2.77; P = 0.005) after multiple adjustments. The 5-year absolute risks (ARs) of all-cause mortality (AR 13.9 [95% CI 10.8-17.0] vs. AR 6.10 [95% CI 4.00-8.30]) and cardiovascular mortality (AR 5.49 [95% CI 3.44-7.55] vs. AR 3.16 [95% CI 1.59-4.73]) were approximately two times higher in the highest quartile of RNA oxidation than in the lowest quartile. CONCLUSIONS: We conclude that high RNA oxidation is associated with all-cause and cardiovascular mortality risk in patients with type 2 diabetes. Targeting oxidative stress via interventions with long-term follow-up may reveal the predictive potential of the biomarker 8-oxoGuo.
引用
- Kjær LK, Cejvanovic V, Henriksen T, et al. Cardiovascular and All-Cause Mortality Risk Associated With Urinary Excretion of 8-oxoGuo, a Biomarker for RNA Oxidation, in Patients With Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care. 2017. PMID: 29061564. doi:10.2337/dc17-1150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。